| The impact of reducing dose frequency on health outcomes A Richter, SE Anton, P Koch, SL Dennett Clinical therapeutics 25 (8), 2307-2335, 2003 | 327 | 2003 |
| An economic review of compliance with medication therapy in the treatment of schizophrenia P Thieda, S Beard, A Richter, J Kane Psychiatric services 54 (4), 508-516, 2003 | 269 | 2003 |
| Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes CDCDC Group Jama 287 (19), 2542-2551, 2002 | 239 | 2002 |
| Resource allocation for control of infectious diseases in multiple independent populations: beyond cost-effectiveness analysis ML Brandeau, GS Zaric, A Richter Journal of health economics 22 (4), 575-598, 2003 | 188 | 2003 |
| Characterizing and diminishing autofluorescence in formalin-fixed paraffin-embedded human respiratory tissue AS Davis, A Richter, S Becker, JE Moyer, A Sandouk, J Skinner, ... Journal of Histochemistry & Cytochemistry 62 (6), 405-423, 2014 | 135 | 2014 |
| Potential savings in the cost of caring for Alzheimer’s disease: treatment with rivastigmine AB Hauber, JA Mauskopf, EH Snyder Pharmacoeconomics 18, 609-612, 2000 | 94 | 2000 |
| Assessing the Saskatchewan database for outcomes research studies of depression and its treatment SL West, A Richter, CA Melfi, M McNutt, ME Nennstiel, JA Mauskopf Journal of clinical epidemiology 53 (8), 823-831, 2000 | 77 | 2000 |
| A linear programming model for allocating HIV prevention funds with state agencies: a pilot study SR Earnshaw, K Hicks, A Richter, A Honeycutt Health Care Management Science 10 (3), 239-252, 2007 | 74 | 2007 |
| Optimal allocation of resources across four interventions for type 2 diabetes SR Earnshaw, A Richter, SW Sorensen, TJ Hoerger, KA Hicks, ... Medical Decision Making 22 (1_suppl), 80-91, 2002 | 73 | 2002 |
| HIV antiretroviral treatment: early versus later J Mauskopf, M Kitahata, T Kauf, A Richter, J Tolson JAIDS Journal of Acquired Immune Deficiency Syndromes 39 (5), 562-569, 2005 | 68 | 2005 |
| An analysis of optimal resource allocation for prevention of infection with human immunodeficiency virus (HIV) in injection drug users and non-users A Richter, ML Brandeau, DK Owens Medical Decision Making 19 (2), 167-179, 1999 | 67 | 1999 |
| Military cost-benefit analysis F Melese, A Richter, B Solomon Taylor & Francis, 2015 | 39 | 2015 |
| Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV‐infected patients: a retrospective cohort study A Richter, M Pladevall, R Manjunath, JE Lafata, H Xi, J Simpkins, I Brar, ... HIV medicine 6 (2), 79-90, 2005 | 39 | 2005 |
| Recommendations for increasing the use of HIV/AIDS resource allocation models A Lasry, A Richter, F Lutscher BMC public health 9, 1-9, 2009 | 30 | 2009 |
| Cost-effectiveness model of cytomegalovirus management strategies in renal transplantation: comparing valaciclovir prophylaxis with current practice JA Mauskopf, A Richter, L Annemans, G Maclaine Pharmacoeconomics 18, 239-251, 2000 | 30 | 2000 |
| Assessing the impact of global price interdependencies A Richter Pharmacoeconomics 26, 649-659, 2008 | 26 | 2008 |
| A Monte Carlo simulation for modelling outcomes of AIDS treatment regimens A Richter, B Hauber, K Simpson, JA Mauskopf, D Yin Pharmacoeconomics 20, 215-224, 2002 | 22 | 2002 |
| Linking defense planning and resource decisions: a return to systems thinking NJ Webb, A Richter, D Bonsper Defense & Security Analysis 26 (4), 387-400, 2010 | 21 | 2010 |
| Pilot model: judging alternate modes of dispensing prophylaxis in Los Angeles County A Richter, S Khan Interfaces 39 (3), 228-240, 2009 | 21 | 2009 |
| Navy Nurse Corps manpower management model DP Kinstler, RW Johnson, A Richter, K Kocher Journal of health organization and management 22 (6), 614-626, 2008 | 18 | 2008 |
Margaret BrandeauStanford UniversityVerified email at stanford.edu
